1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Univariate analysis of survival outcomes for patients with AG
Characteristic PFS OS P Value HR 95% CI P Value HR 95% CI Age 50 yr or older <.001 1.813 1.318–2.494 .007 1.729 1.134–2.421 Sex (male) .215 0.873 0.695–1.064 .415 0.914 0.612–1.283 Preoperative KPS < 80 .004 2.603 1.154–3.548 .002 2.872 1.270–3.341 Enhancement .570 1.200 0.641–2.247 .625 1.187 0.596–2.365 Enhancement pattern .150 1.107 0.964–1.271 .247 1.902 0.941–1.266 <GTR/GTR .001 1.734 1.237–2.429 <.001 1.926 1.346–2.758 Histopathology .086 0.855 0.715–1.022 .054 0.789 0.654–1.002 IDH1 wild type .002 2.364 1.362–4.098 .004 2.688 1.231–4.717